Product Information
TRIPLE ANTIBIOTIC OINTMENT is a generic product labeled by BluePoint Laboratories, priced at $0.1391 per GM under NDC 68001048346. Its NADAC has been published 257 times since Nov 3, 2021.
Strength
400; 3.5; 5000 [iU]/g; mg/g; [iU]/g
Manufacturer
BluePoint LaboratoriesNDC
68001048346
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
6/15/2021
Pharmacological Classes
Price Statistics
The NADAC for TRIPLE ANTIBIOTIC OINTMENT has been published 257 times since Nov 3, 2021, and over the history we have for it it has declined 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1391 per GM |
|---|---|
| All-time high | $0.1486 (Oct 12, 2022) |
| All-time low | $0.1246 (Jan 19, 2022) |
| 52-week high | $0.1402 |
| 52-week low | $0.1344 |
| Median price | $0.1391 |
| Average price | $0.1385 |
| Largest weekly change | -13.2% (Jan 19, 2022) |
| Weeks tracked | 257 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
First Aid Antibiotic market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIPLE ANTIBIOTIC OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TRIPLE ANTIBIOTIC OINTMENT, manufactured by BluePoint Laboratories, is $0.1391 per GM (NDC 68001048346), effective Sep 30, 2026.
How has the price of TRIPLE ANTIBIOTIC OINTMENT changed over time?
Over the history we have for it, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has declined 3.2%. It has been tracked across 257 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for TRIPLE ANTIBIOTIC OINTMENT?
Since Nov 3, 2021, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has ranged from a low of $0.1246 (Jan 19, 2022) to a high of $0.1486 (Oct 12, 2022), with a median of $0.1391 per GM.
Are there cheaper alternatives to TRIPLE ANTIBIOTIC OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIPLE ANTIBIOTIC OINTMENT, is $0.1109 per GM — about 20% below TRIPLE ANTIBIOTIC OINTMENT.
Who manufactures TRIPLE ANTIBIOTIC OINTMENT?
TRIPLE ANTIBIOTIC OINTMENT (NDC 68001048346) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.